CERO is a wild card for traders craving action. This high-volatility ticker can rocket sky-high or dive deep—perfect for those ready to capitalize on sharp swings. Timing is everything, so ride the momentum and lock in gains!
ノート
A significant pipeline drug gaining approval would boost investor confidence.
Securing funding or partnerships with larger pharmaceutical companies.
Increased Revenue: Reporting earnings or securing grants that reduce cash burn